Dry Eye Syndrome Treatment Market

Global Market Study on Dry Eye Syndrome Treatment: Launch of Innovative Treatment Products Complementing Market Growth

Dry Eye Syndrome Treatment Market Segmented By Cyclosporine, Topical Corticosteroids, Artificial Tears, Punctal Plugs, Omega Supplements Product with Rx, OTC, Medical Devices Prescription

  • March-2021
  • PMRREP32300
  • 314 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusion and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Method Innovation / Development Trends

4. Key Success Factors

    4.1. Dry Eye Syndrome Epidemiology, By Country, 2015-2030

        4.1.1. Prevalence of dry eye disease 

        4.1.2. Potential patient number of dry eye disease

        4.1.3. Percentage of severity, mild, modulate, and severe

        4.1.4. Patients number under treatment

        4.1.5. Prevalence of MGD and occurrence rate of dry eye among MGD patient

    4.2. Regulatory Scenario

    4.3. New Product Launches

    4.4. Reimbursement Scenario

    4.5. Dry Eye Syndrome- Diagnostics protocol/ Criteria by key countries

    4.6. Dry Eye Syndrome – Patient Treatment Journey

5. Market Background

    5.1. Macro-Economic Factors 

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Industry Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Increase in Geriatric Population 

        5.2.2. Increasing Prevalence of Dry Eye Syndrome 

        5.2.3. Limited Awareness About Dry Eye Syndrome 

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Trends

        5.3.4. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. COVID19 and Impact Analysis

        6.3.1. Revenue By Product Type 

        6.3.2. Revenue By Distribution Channel 

        6.3.3. By Prescription Type

        6.3.4. Revenue By Country

7. Global Dry Eye Syndrome Market Demand (In Volume Units) Analysis 2015–2019 and Forecast, 2020–2030

    7.1. Historical Market (Volume) Analysis, 2015–2019

    7.2. Current and Future Market (Volume) Projections, 2020–2030

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Dry Eye Syndrome Market- Pricing Analysis

    8.1. Regional Pricing Analysis By Product

9. Global Dry Eye Syndrome Market  Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020–2030

    9.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

    9.2. Current and Future Market Value (US$ Mn) Projections, 2020–2030

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Product Type 

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020–2030

        10.3.1. Cyclosporin

        10.3.2. Topical Corticosteroids

        10.3.3. Artificial Tears

        10.3.4. Punctal plugs

            10.3.4.1. Removable 

            10.3.4.2. Dissolvable

        10.3.5. Omega Supplements

        10.3.6. Others

    10.4. Others Market Attractiveness Analysis By Product Type

11. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Prescription Type 

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) By Prescription Type, 2015-2019

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Prescription Type, 2020–2030

        11.3.1. Rx

        11.3.2. OTC

        11.3.3. Medical Device

    11.4. Others Market Attractiveness Analysis By Prescription Type

12. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, By Distribution Channel 

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) By Distribution Channel, 2015-2019

    12.3. Current and Future Market Size (US$ Mn)) Analysis and Forecast By Distribution Channel, 2020–2030

        12.3.1. Hospital Pharmacies

        12.3.2. Eye Health Clinics

        12.3.3. Retail Pharmacies

        12.3.4. Online Pharmacies

    12.4.  Market Attractiveness Analysis By Distribution Channel

13. Global Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015 - 2019

    13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2020 - 2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia

        13.3.6. Oceania

        13.3.7. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Product Type

        14.3.3. By Prescription Type

        14.3.4. By Distribution Channel 

    14.4. Market Attractiveness Analysis

    14.5. Drivers and Restraints - Impact Analysis

15. Latin America Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015 - 2019

    15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2020–2030

        15.3.1.  By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Rest of Latin America

        15.3.2. By Product Type

        15.3.3. By Prescription Type

        15.3.4. By Distribution Channel 

    15.4. Market Attractiveness Analysis

    15.5. Drivers and Restraints - Impact Analysis

16. Europe Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    16.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy 2020–2030

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. Russia

            16.3.1.7. Poland

            16.3.1.8. Rest of Europe

        16.3.2. By Product Type

        16.3.3. By Prescription Type

        16.3.4. By Distribution Channel 

    16.4. Market Attractiveness Analysis

    16.5. Drivers and Restraints - Impact Analysis

17. South Asia Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy2020–2030

        17.3.1.  By Country

            17.3.1.1. India

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Vietnam

            17.3.1.6. Rest of South Asia

        17.3.2. By Product Type

        17.3.3. By Prescription Type

        17.3.4. By Distribution Channel 

    17.4. Market Attractiveness Analysis

    17.5. Drivers and Restraints - Impact Analysis

18. East Asia Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

        18.3.1.  By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Product Type

        18.3.3. By Prescription Type

        18.3.4. By Distribution Channel 

    18.4. Market Attractiveness Analysis

    18.5. Drivers and Restraints - Impact Analysis

19. Oceania Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2015-2019

    19.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

        19.3.1.  By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Product Type

        19.3.3. By Prescription Type

        19.3.4. By Distribution Channel 

    19.4. Market Attractiveness Analysis

    19.5. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Dry Eye Syndrome Market  Analysis 2015-2019 and Forecast 2020–2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019

    20.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2020–2030

        20.3.1.  By Country

            20.3.1.1. GCC Countries

            20.3.1.2. South Africa

            20.3.1.3. North Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Product Type

        20.3.3. By Prescription Type

        20.3.4. By Distribution Channel 

    20.4. Market Attractiveness Analysis

    20.5. Drivers and Restraints - Impact Analysis

21. Key Countries Dry Eye Syndrome Market   Analysis 2015-2019 and Forecast 2020–2030

    21.1. U.S. Dry Eye Syndrome Market   Analysis

        21.1.1. By Product Type

        21.1.2. By Prescription Type

        21.1.3. By Distribution Channel 

    21.2. Canada Dry Eye Syndrome Market   Analysis

        21.2.1. By Product Type

        21.2.2. By Prescription Type

        21.2.3. By Distribution Channel 

    21.3. Brazil Dry Eye Syndrome Market   Analysis

        21.3.1. By Product Type

        21.3.2. By Prescription Type

        21.3.3. By Distribution Channel 

    21.4. Mexico Dry Eye Syndrome Market   Analysis

        21.4.1. By Product Type

        21.4.2. By Prescription Type

        21.4.3. By Distribution Channel 

    21.5. U.K. Dry Eye Syndrome Market   Analysis

        21.5.1. By Product Type

        21.5.2. By Prescription Type

        21.5.3. By Distribution Channel 

    21.6. Germany Dry Eye Syndrome Market   Analysis

        21.6.1. By Product Type

        21.6.2. By Prescription Type

        21.6.3. By Distribution Channel 

    21.7. France Dry Eye Syndrome Market   Analysis

        21.7.1. By Product Type

        21.7.2. By Prescription Type

        21.7.3. By Distribution Channel 

    21.8. Italy Dry Eye Syndrome Market   Analysis

        21.8.1. By Product Type

        21.8.2. By Prescription Type

        21.8.3. By Distribution Channel 

    21.9. Spain Dry Eye Syndrome Market   Analysis

        21.9.1. By Product Type

        21.9.2. By Prescription Type

        21.9.3. By Distribution Channel 

    21.10. Russia Dry Eye Syndrome Market   Analysis

        21.10.1. By Product Type

        21.10.2. By Prescription Type

        21.10.3. By Distribution Channel 

    21.11. Poland Dry Eye Syndrome Market   Analysis

        21.11.1. By Product Type

        21.11.2. By Prescription Type

        21.11.3. By Distribution Channel 

    21.12. Japan Dry Eye Syndrome Market   Analysis

        21.12.1. By Product Type

        21.12.2. By Prescription Type

        21.12.3. By Distribution Channel 

    21.13. China Dry Eye Syndrome Market   Analysis

        21.13.1. By Product Type

        21.13.2. By Prescription Type

        21.13.3. By Distribution Channel 

    21.14. South Korea Dry Eye Syndrome Market   Analysis

        21.14.1. By Product Type

        21.14.2. By Prescription Type

        21.14.3. By Distribution Channel 

    21.15. India Dry Eye Syndrome Market   Analysis

        21.15.1. By Product Type

        21.15.2. By Prescription Type

        21.15.3. By Distribution Channel 

    21.16. Thailand Dry Eye Syndrome Market   Analysis

        21.16.1. By Product Type

        21.16.2. By Prescription Type

        21.16.3. By Distribution Channel 

    21.17. Indonesia Dry Eye Syndrome Market   Analysis

        21.17.1. By Product Type

        21.17.2. By Prescription Type

        21.17.3. By Distribution Channel 

    21.18. Malaysia Dry Eye Syndrome Market   Analysis

        21.18.1. By Product Type

        21.18.2. By Prescription Type

        21.18.3. By Distribution Channel 

    21.19. Vietnam Dry Eye Syndrome Market   Analysis

        21.19.1. By Product Type

        21.19.2. By Prescription Type

        21.19.3. By Distribution Channel 

    21.20. Australia Dry Eye Syndrome Market   Analysis

        21.20.1. By Product Type

        21.20.2. By Prescription Type

        21.20.3. By Distribution Channel 

    21.21. New Zealand Dry Eye Syndrome Market   Analysis

        21.21.1. By Product Type

        21.21.2. By Prescription Type

        21.21.3. By Distribution Channel 

    21.22. GCC Countries Dry Eye Syndrome Market   Analysis

        21.22.1. By Product Type

        21.22.2. By Prescription Type

        21.22.3. By Distribution Channel 

    21.23. South Africa Dry Eye Syndrome Market   Analysis

        21.23.1. By Product Type

        21.23.2. By Prescription Type

        21.23.3. By Distribution Channel 

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies 

    22.2. Market Concentration

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Deep Dive 

        23.2.1. Allergan Plc.

            23.2.1.1. Product Portfolio

            23.2.1.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.1.3. Sales Footprint

            23.2.1.4. Strategy Overview

                23.2.1.4.1. Marketing Strategy

                23.2.1.4.2. Product Strategy

                23.2.1.4.3. Channel Strategy

        23.2.2. Novartis AG

            23.2.2.1. Product Portfolio

            23.2.2.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.2.3. Sales Footprint

            23.2.2.4. Strategy Overview

                23.2.2.4.1. Marketing Strategy

                23.2.2.4.2. Product Strategy

                23.2.2.4.3. Channel Strategy

        23.2.3. Otsuka Pharmaceutical Co.,Ltd.

            23.2.3.1. Product Portfolio

            23.2.3.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.3.3. Sales Footprint

            23.2.3.4. Strategy Overview

                23.2.3.4.1. Marketing Strategy

                23.2.3.4.2. Product Strategy

                23.2.3.4.3. Channel Strategy

        23.2.4. Santen Pharmaceutical Co Ltd.

            23.2.4.1. Product Portfolio

            23.2.4.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.4.3. Sales Footprint

            23.2.4.4. Strategy Overview

                23.2.4.4.1. Marketing Strategy

                23.2.4.4.2. Product Strategy

                23.2.4.4.3. Channel Strategy

        23.2.5. Bausch Health Companies Inc.

            23.2.5.1. Product Portfolio

            23.2.5.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.5.3. Sales Footprint

            23.2.5.4. Strategy Overview

                23.2.5.4.1. Marketing Strategy

                23.2.5.4.2. Product Strategy

                23.2.5.4.3. Channel Strategy

        23.2.6. Akorn, Inc. 

            23.2.6.1. Product Portfolio

            23.2.6.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.6.3. Sales Footprint

            23.2.6.4. Strategy Overview

                23.2.6.4.1. Marketing Strategy

                23.2.6.4.2. Product Strategy

                23.2.6.4.3. Channel Strategy

        23.2.7. Johnson & Johnson, Inc.

            23.2.7.1. Product Portfolio

            23.2.7.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.7.3. Sales Footprint

            23.2.7.4. Strategy Overview

                23.2.7.4.1. Marketing Strategy

                23.2.7.4.2. Product Strategy

                23.2.7.4.3. Channel Strategy

        23.2.8. Thea Pharmaceuticals Limited

            23.2.8.1. Product Portfolio

            23.2.8.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.8.3. Sales Footprint

            23.2.8.4. Strategy Overview

                23.2.8.4.1. Marketing Strategy

                23.2.8.4.2. Product Strategy

                23.2.8.4.3. Channel Strategy

        23.2.9. OASIS Medical

            23.2.9.1. Product Portfolio

            23.2.9.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.9.3. Sales Footprint

            23.2.9.4. Strategy Overview

                23.2.9.4.1. Marketing Strategy

                23.2.9.4.2. Product Strategy

                23.2.9.4.3. Channel Strategy

        23.2.10. Altaire Pharmaceuticals Inc.

            23.2.10.1. Product Portfolio

            23.2.10.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.10.3. Sales Footprint

            23.2.10.4. Strategy Overview

                23.2.10.4.1. Marketing Strategy

                23.2.10.4.2. Product Strategy

                23.2.10.4.3. Channel Strategy

        23.2.11. Boiron USA 

            23.2.11.1. Product Portfolio

            23.2.11.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.11.3. Sales Footprint

            23.2.11.4. Strategy Overview

                23.2.11.4.1. Marketing Strategy

                23.2.11.4.2. Product Strategy

                23.2.11.4.3. Channel Strategy

        23.2.12. Similasan Corporation

            23.2.12.1. Product Portfolio

            23.2.12.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.12.3. Sales Footprint

            23.2.12.4. Strategy Overview

                23.2.12.4.1. Marketing Strategy

                23.2.12.4.2. Product Strategy

                23.2.12.4.3. Channel Strategy

        23.2.13. Scope Ophthalmics Ltd.

            23.2.13.1. Product Portfolio

            23.2.13.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.13.3. Sales Footprint

            23.2.13.4. Strategy Overview

                23.2.13.4.1. Marketing Strategy

                23.2.13.4.2. Product Strategy

                23.2.13.4.3. Channel Strategy

        23.2.14. Reckitt Benckiser Group PLC

            23.2.14.1. Product Portfolio

            23.2.14.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.14.3. Sales Footprint

            23.2.14.4. Strategy Overview

                23.2.14.4.1. Marketing Strategy

                23.2.14.4.2. Product Strategy

                23.2.14.4.3. Channel Strategy

        23.2.15. Medicom Healthcare Ltd 

            23.2.15.1. Product Portfolio

            23.2.15.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.15.3. Sales Footprint

            23.2.15.4. Strategy Overview

                23.2.15.4.1. Marketing Strategy

                23.2.15.4.2. Product Strategy

                23.2.15.4.3. Channel Strategy

        23.2.16. FDC Limited.

            23.2.16.1. Product Portfolio

            23.2.16.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.16.3. Sales Footprint

            23.2.16.4. Strategy Overview

                23.2.16.4.1. Marketing Strategy

                23.2.16.4.2. Product Strategy

                23.2.16.4.3. Channel Strategy

        23.2.17. Lupin Limited 

            23.2.17.1. Product Portfolio

            23.2.17.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.17.3. Sales Footprint

            23.2.17.4. Strategy Overview

                23.2.17.4.1. Marketing Strategy

                23.2.17.4.2. Product Strategy

                23.2.17.4.3. Channel Strategy

        23.2.18. Jamjoom Pharmaceuticals Co. 

            23.2.18.1. Product Portfolio

            23.2.18.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.18.3. Sales Footprint

            23.2.18.4. Strategy Overview

                23.2.18.4.1. Marketing Strategy

                23.2.18.4.2. Product Strategy

                23.2.18.4.3. Channel Strategy

        23.2.19. Sentiss Pharma Private limited 

            23.2.19.1. Product Portfolio

            23.2.19.2. Profitability by Market Segments (Drugs/Channel/Region)

            23.2.19.3. Sales Footprint

            23.2.19.4. Strategy Overview

                23.2.19.4.1. Marketing Strategy

                23.2.19.4.2. Product Strategy

                23.2.19.4.3. Channel Strategy

24.  Assumptions and Acronyms Used

25. Research Methodology

Find Out More about the Report Coverage

List of Tables

Table 01: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 02: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 03: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 04: Global Dry Eye Syndrome Treatment Market size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region

Table 05: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 06: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 07: North America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 08: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 09: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 10: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 11: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 12: Latin America Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 13: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 14: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 15: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 16: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 17: Europe Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 18: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 19: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 20: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 21: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 22: South Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 23: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 24: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 25: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 26: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 27: East Asia Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 28: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 29: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 30: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 31: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 32: Oceania Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 33: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 34: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Table 35: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country

Table 36: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 37: MEA Dry Eye Syndrome Treatment Volume (000’ Units) Analysis 2015-2019 and Forecast 2020-2030, By Product Type

Table 38: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Prescription Type

Table 39: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

Explore Persistence Market Research’s expertise in promulgation of the business !

List of Chart

Figure 01: Global Dry Eye Syndrome Treatment Market Volume Analysis (000’ Units), 2015-2019

Figure 02: Dry Eye Syndrome Treatment Market Volume Forecast (000’ Units), 2020-2030

Figure 03: Cyclosporine Pricing Analysis (US$) for Per Unit (Per pack of 60 0.4 ml vials), By Region, 2019

Figure 04: Topical Corticosteroids Pricing Analysis (US$) for Per Unit (Per 5ml bottle), By Region, 2019

Figure 05: Artificial Tears Pricing Analysis (US$) for Per Unit (Per pack of 15 ml), By Region, 2019

Figure 06: Removable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2019

Figure 07: Dissolvable Punctal Plugs Pricing Analysis (US$) for Per Unit (Per pack of one pair), By Region, 2019

Figure 08: Oral Omega Supplements Corticosteroids Pricing Analysis (US$) for Per Unit (Per pack of 120 capsules), By Region, 2019

Figure 09: Global Dry Eye Syndrome Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

Figure 10: Global Dry Eye Syndrome Treatment Market Value (US$ Mn), 2015-2019

Figure 11: Global Dry Eye Syndrome Treatment Market Absolute $ Opportunity (US$ Mn), 2019-2030

Figure 12: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Product Type, 2020 & 2030

Figure 13: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Product Type, 2019-2030

Figure 14: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Product Type, 2020-2030

Figure 15: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Prescription Type, 2020 & 2030

Figure 16: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Prescription Type, 2019-2030

Figure 17: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Prescription Type, 2020-2030

Figure 18: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2020 & 2030

Figure 19: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Distribution Channel, 2019-2030

Figure 20: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2020-2030

Figure 21: Global Dry Eye Syndrome Treatment Market Share Analysis (%) By Region, 2020 & 2030

Figure 22: Global Dry Eye Syndrome Treatment Market Y-o-Y Growth (%) By Region, 2019-2030

Figure 23: Global Dry Eye Syndrome Treatment Market Attractiveness Analysis By Region, 2020-2030

Figure 24: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 25: North America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 26: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 27: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 28: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 29: North America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 30: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 31: Latin America Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 32: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 33: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 34: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 35: Latin America Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 36: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 37: Europe Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 38: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 39: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 40: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 41: Europe Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 42: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 43: South Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 44: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 45: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 46: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 47: South Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 48: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 49: East Asia Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 50: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 51: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 52: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 53: East Asia Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 54: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 55: Oceania Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 56: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 57: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 58: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 59: Oceania Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 60: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) Analysis, 2015-2019

Figure 61: MEA Dry Eye Syndrome Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2019-2030

Figure 62: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Product Type

Figure 63: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Prescription Type

Figure 64: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Distribution Channel 

Figure 65: MEA Dry Eye Syndrome Treatment Market Attractiveness Analysis, By Country

Figure 66: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 67: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 68: U.S. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 69: U.S. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 70: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 71: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 72: Canada Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 73: Canada Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 74: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 75: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 76: Brazil Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 77: Brazil Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 78: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 79: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 80: Mexico Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 81: Mexico Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 82: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 83: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 84: U.K. Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 85: U.K. Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 86: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 87: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 88: Germany Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 89: Germany Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 90: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 91: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 92: France Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 93: France Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 94: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 95: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 96: Italy Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 97: Italy Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 98: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 99: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 100: Spain Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 101: Spain Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 102: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 103: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 104: Russia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 105: Russia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 106: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 107: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 108: Poland Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 109: Poland Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 110: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 111: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 112: Japan Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 113: Japan Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 114: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 115: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 116: China Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 117: China Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 118: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 119: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 120: South Korea Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 121: South Korea Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 122: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 123: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 124: India Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 125: India Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 126: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 127: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 128: Thailand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 129: Thailand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 130: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 131: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 132: Indonesia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 133: Indonesia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 134: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 135: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 136: Malaysia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 137: Malaysia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 138: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 139: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 140: Vietnam Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 141: Vietnam Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 142: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 143: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 144: Australia Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 145: Australia Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 146: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 147: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 148: New Zealand Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 149: New Zealand Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 150: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 151: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 152: GCC Countries Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 153: GCC Countries Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Figure 154: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Product, 2019 & 2030

Figure 155: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Prescription Type, 2019 & 2030

Figure 156: South Africa Dry Eye Syndrome Treatment Market Share Analysis (%), by Distribution Channel, 2019 & 2030

Figure 157: South Africa Dry Eye Syndrome Treatment Market Value Analysis (US$ Mn), 2019 & 2030

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Description

Dry Eye Syndrome Treatment Market - Scope of Report

A latest publication by Persistence Market Research on the global dry eye syndrome treatment market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the market. The report offers a detailed study of the market background, which includes macroeconomic factors, forecast factors, drivers, restraints, trends, and opportunities in the market. The principal aim of the study is to present exclusive information about how the market will perform over the forecast period of 2020-2030.

Important indicators for successful growth in the dry eye syndrome treatment market are presented in this comprehensive report, which include Year-on-Year (Y-o-Y) growth analysis of the market and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for dry eye syndrome treatment and quantitative development opportunities during the study period.

The research is beneficial for shareholders in the market, including market investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the dry eye syndrome treatment market. Insights and wisdom presented in this study can be leveraged by shareholders, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the dry eye syndrome treatment market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, under the data submitted in this market report, minor companies and new entrants in the dry eye syndrome treatment industry can be aided in making suitable company choices to achieve traction in market.

Key Market Segments

Persistence Market Research’s study on the dry eye syndrome treatment market offers information divided into four important segments— product, prescription, distribution channel, and region. This report offers comprehensive data and information about important market dynamics and growth parameters associated with these categories.

Product

  • Cyclosporine
  • Topical Corticosteroids
  • Artificial Tears
  • Punctal Plugs
    • Removable
    • Dissolvable
  • Omega Supplements
  • Others

Prescription

  • Rx
  • OTC
  • Medical Device

Distribution Channel

  • Hospital Pharmacies
  • Eye Health Clinics
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable regional markets for dry eye syndrome treatment?
  • Which factors will induce a change in the demand for dry eye syndrome treatment during the assessment period?
  • How will changing trends impact the market?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the dry eye syndrome treatment market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends in ophthalmic sectors that will impact the market?
  • How can businesses avail the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the dry eye syndrome treatment market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the dry eye syndrome treatment market, and makes Persistence Market Research’s projections on the growth prospects of the market more accurate and reliable.

Recommendations

Polyol Ester Market

As per PMR's research study, global polyol ester market anticipated to rise at a robust CAGR of 5.1% along with a healthy revenue during the forecast period of 2017-2027.

Isoparaffin Solvents Market

The incremental $ opportunity created by the market during the forecast period is pegged at nearly US$ 51.9 Mn. The isoparaffin solvents market is expected to expand at a CAGR of 3.7% during the forecast period..

Propylene Glycol Ether Market

The global propylene glycol ether market is estimated to have been valued at US$ 1,604.1 Mn by 2017 end and is expected to reach US$ 2,088.4 Mn by the end of 2026 while expanding at a CAGR of 3.0% over the forecast period. .

Asia Pacific North America Europe Fluorinated Solvents Market

The Asia Pacific Fluorinated Solvents market is expected to register a CAGR of 9.0% over the forecast period (2018–2026)..

Our Clients

Our Clients